Nationwide Fund Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Nationwide Fund Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,331	Closed	-$61K	–	3274
2016 Q4	$61K	Hold	12,331	–	–	﹤0.01%	2980
2016 Q3	$61K	Hold	12,331	–	–	﹤0.01%	3021
2016 Q2	$63K	Hold	12,331	–	–	﹤0.01%	3045
2016 Q1	$70K	Hold	12,331	–	–	﹤0.01%	2923
2015 Q4	$128K	Hold	12,331	–	–	﹤0.01%	2757
2015 Q3	$228K	Hold	12,331	–	–	﹤0.01%	2496
2015 Q2	$240K	Sell	12,331 -1,579	-11%	-$27.9K	﹤0.01%	2613
2015 Q1	$245K	Sell	13,910 -791	-5%	-$13.3K	﹤0.01%	2594
2014 Q4	$235K	Buy	14,701 +152	+1%	+$2.04K	﹤0.01%	2542
2014 Q3	$183K	Buy	14,549 +134	+0.9%	+$1.91K	﹤0.01%	2741
2014 Q2	$225K	Buy	14,415 +1,554	+12%	+$22.9K	﹤0.01%	2693
2014 Q1	$169K	Sell	12,861 -119	-0.9%	-$1.86K	﹤0.01%	2558
2013 Q4	$209K	Sell	12,980 -211	-2%	-$3.36K	﹤0.01%	2671
2013 Q3	$219K	Buy	13,191 +588	+5%	+$8.69K	﹤0.01%	2609
2013 Q2	$127K	Buy	+12,603	New	+$132K	﹤0.01%	2705

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Nationwide Fund Advisors's OSIR Position: Q1 2017 in Review

Nationwide Fund Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 12,331 shares — an estimated $61K sold.

Nationwide Fund Advisors first reported a position in OSIR in Q2 2013 and held it in 15 quarters. The position peaked at $245K in Q1 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

Nationwide Fund Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 12,331 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $61K.
Nationwide Fund Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
Nationwide Fund Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $245K in Q1 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Nationwide Fund Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.